Virtus ETF Advisers LLC Vir Biotechnology, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 8,894 shares of VIR stock, worth $63,325. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,894

Previous 8,738 1.79%

Holding current value

$63,325

Previous $77,000 14.29%

% of portfolio

0.03%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $1,132 - $1,669	156 Added 1.79%	8,894 $66,000
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $824 - $1,367	108 Added 1.25%	8,738 $77,000
Q1 2024 May 15, 2024	SELL	$8.6 - $11.9 $5,082 - $7,032	-591 Reduced 6.41%	8,630 $87,000
Q4 2023 Feb 15, 2024	BUY	$7.76 - $10.29 $42,051 - $55,761	5,419 Added 142.53%	9,221 $92,000
Q3 2023 Nov 07, 2023	SELL	$9.14 - $24.62 $3,445 - $9,281	-377 Reduced 9.02%	3,802 $35,000
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $6,356 - $7,477	274 Added 7.02%	4,179 $102,000
Q1 2023 May 15, 2023	SELL	$22.26 - $30.85 $33,456 - $46,367	-1,503 Reduced 27.79%	3,905 $90,000
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $14,231 - $20,120	713 Added 15.19%	5,408 $136,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $657 - $1,119	36 Added 0.77%	4,695 $91,000
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $24,517 - $34,309	1,285 Added 38.09%	4,659 $119,000
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $4,110 - $7,761	-194 Reduced 5.44%	3,374 $87,000
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $33,943 - $59,216	-1,096 Reduced 23.5%	3,568 $149,000
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $8,655 - $13,525	-248 Reduced 5.05%	4,664 $203,000
Q2 2021 Aug 10, 2021	SELL	$38.75 - $51.0 $166,702 - $219,402	-4,302 Reduced 46.69%	4,912 $232,000
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $4,477 - $14,121	170 Added 1.88%	9,214 $472,000
Q4 2020 Feb 12, 2021	BUY	$25.51 - $43.38 $1,096 - $1,865	43 Added 0.48%	9,044 $242,000
Q3 2020 Nov 13, 2020	SELL	$28.28 - $53.6 $34,643 - $65,660	-1,225 Reduced 11.98%	9,001 $309,000
Q2 2020 Aug 05, 2020	BUY	$27.89 - $47.86 $285,203 - $489,416	10,226 New	10,226 $419,000

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Vir Biotechnology, Inc. Transaction History